Results 121 to 130 of about 1,915,304 (214)

Intrastent haematoma after treatment with a drug-eluting balloon for in-stent restenosis: a case report. [PDF]

Eur Heart J Case Rep, 2021
Hong XL, Fu GS, Li ZL, Zhang WB.
europepmc   +1 more source

Drug-eluting balloon as an alternative to coronary stent in the treatment of de novo atherosclerotic lesions of native coronary arteries — the future we have already been in? Review

Кардиоваскулярная терапия и профилактика
In the last decade, the disadvantages of coronary artery (CA) drugeluting stenting have become increasingly obvious. Metallization of the artery, loss of vasoreactivity and chronic inflammation at the implantation site lead to restenosis and an increased
D. K. Vasiliev, N. A. Arablinsky
doaj   +1 more source

Drug-eluting balloon (DEB) versus plain old balloon angioplasty (POBA) in the treatment of failing dialysis access: A prospective randomized trial. [PDF]

J Int Med Res, 2022
Fransson T, Gottsäter A, Abdulrasak M, Malina M, Resch T.   +4 more
europepmc   +1 more source

Clinical utility of self-expanding stents in coronary artery disease

Research Reports in Clinical Cardiology, 2015
Aditya R Boddu, Abilash R Balmuri, Masoor Kamalesh Department of Cardiology, Krannert Institute of Cardiology, Richard L Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis, IN, USA Abstract: The field of percutaneous ...
Boddu AR, Balmuri AR, Kamalesh M
doaj  

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform

, 2013
Everolimus-eluting stents (EES) represent the next generation of drug-eluting stents (DES). Important design modifications include thin strut stent backbones, less inflammatory and more biocompatible polymers, and lower drug dosing.
Robert J. Applegate, Matthew G. Whitbeck
core   +1 more source

New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease

, 2016
Jesse Naghi, Ethan A Yalvac, Ali Pourdjabbar, Lawrence Ang, John Bahadorani, Ryan R Reeves, Ehtisham Mahmud, Mitul Patel Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, CA, USA Abstract ...
Ang L, Bahadorani J, Yalvac EA, Pourdjabbar A, Naghi J, Mahmud E, Reeves RR, Patel M   +7 more
core  

Drug eluting balloon evaluation in de-novo non-LAD stenoses

Indian Heart Journal, 2014
J.S. Hiremath, K.S. Sheth, C.N. Makhale
doaj   +1 more source

Long-term outcomes following drug-eluting balloon or thin-strut drug-eluting stents for treatment of in-stent restenosis stratified by duration of dual antiplatelet therapy (DEB-Dragon Registry). [PDF]

Postepy Kardiol Interwencyjnej, 2022
Januszek R, Bil J, Gilis-Malinowska N, Staszczak B, Figatowski T, Milewski M, Mielczarek M, Dylewski Ł, Wybraniec M, Tomasiewicz B, Kübler P, Walczak T, Hrymniak B, Desperak P, Niezgoda P, Wolny R, Chudzik M, Smolka G, Ciećwierz D, Reczuch K, Gruchała M, Kubica J, Gil RJ, Kedhi E, D'Ascenzo F, Balan R, Pawlik A, Kuźma Ł, Dobrzycki S, Hudziak D, Bartuś S, Gąsior M, Ochała A, Witkowski A, Jaguszewski M, Wojakowski W, Wańha W.   +36 more
europepmc   +1 more source

How real is a threat of late thrombosis for drug-eluting stents? Stent comparison and focus on everolimus

Кардиоваскулярная терапия и профилактика, 2009
Introducing drug-eluting stents (DES) is an important achievement in interventional cardiology. These stents have demonstrated good clinical results, effectiveness and safety.
V. P. Lupanov, A. N. Samko, G. N. Bakashvili   +2 more
doaj  

Carotid in-stent restenosis and re-restenosis treated with drug-eluting balloon dilation – case report and literature review

According to relevant multicenter studies, significant in-stent stenosis develops in 5-6% of cases after internal carotid artery stenting. We present the risks, pathomechanism, diagnostics and treatment options of in-stent stenosis, the evidence, and the
Csaba Zsolt Oláh, Benedek Oláh
core   +1 more source